Aurinia Pharmaceuticals
AUPH
#4707
Rank
S$2.81 B
Marketcap
S$21.04
Share price
-0.12%
Change (1 day)
8.60%
Change (1 year)

EPS for Aurinia Pharmaceuticals (AUPH)

EPS in 2023 (TTM): S-$0.71

According to Aurinia Pharmaceuticals 's latest financial reports the company's current EPS (TTM) is S$3.06. In 2022 the company made an earnings per share (EPS) of S-$0.97 an increase over its 2021 EPS that were of S-$1.80.

EPS history for Aurinia Pharmaceuticals from 1999 to 2023

Annual EPS

Year EPS Change
2023 (TTM)S-$0.71-26.83%
2022S-$0.97-46.1%
2021S-$1.8063.95%
2020S-$1.10-33.85%
2019S-$1.6673.33%
2018S-$0.96-34.78%
2017S-$1.4774.24%
2016S-$0.8413.79%
2015S-$0.74-15.94%
2014S-$0.8861.51%
2013S-$0.55-83.03%
2012S-$3.22621.77%
2011S-$0.45-75.81%
2010S-$1.85-53.29%
2009S-$3.95-59.15%
2008S-$9.67-50.57%
2007S-$19.5716.07%
2006S-$16.86-28.86%
2005S-$23.7025.38%
2004S-$18.9051.08%
2003S-$12.514032.42%
2002S-$0.30
2000S-$11.25290.68%
1999S-$2.88

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Regeneron Pharmaceuticals
REGN
S$53.64 1,653.56%๐Ÿ‡บ๐Ÿ‡ธ USA
Pieris Pharmaceuticals
PIRS
S-$22.53-836.40%๐Ÿ‡บ๐Ÿ‡ธ USA
Aeterna Zentaris
AEZS
S-$2.62-185.73%๐Ÿ‡บ๐Ÿ‡ธ USA